Business Context and Reporting Period
Alector, Inc. (ALEC) filed a Current Report on Form 8-K dated May 7, 2026. The filing reports the entry into a Material Definitive Agreement to facilitate the sale of common stock.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, or debt levels. The primary financial metric disclosed is the authorization of a potential capital raise:
- Maximum Offering Size: Up to $125,000,000 of common stock.
- Commission Fee: Up to 3.0% of the gross sales price per share.
- Proceeds Usage: General corporate purposes, including R&D, manufacturing, working capital, capital expenditures, and potential strategic transactions.
Material Changes
The material change reported is the execution of a Sales Agreement with TD Securities (USA) LLC ("TD Cowen") on May 7, 2026. This agreement establishes an "at-the-market" (ATM) facility allowing the Company to sell shares from time to time. The offering is registered under a shelf registration statement (Form S-3) declared effective on April 30, 2026.
Outlook, Risks, and Management Commentary
- Flexibility: The Company is not obligated to sell any shares and may set parameters for sales, including minimum prices and daily volume limits.
- Termination: Either party may terminate the agreement with 10 days' written notice. Immediate termination is possible upon a Material Adverse Change.
- Strategic Intent: Management intends to use net proceeds for product development and general corporate needs but has no specific acquisition commitments at this time.
- Risks: The filing notes customary indemnification obligations to TD Cowen regarding liabilities under the Securities Act of 1933 and the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the current market price of Alector stock to assess potential dilution impact if the full $125 million is sold.
- Review the full text of the Sales Agreement (Exhibit 1.1) for specific minimum price thresholds and daily sales limits.
- Monitor subsequent filings to determine if and when shares are actually sold under this facility.
- Check the Company's cash position in the most recent 10-Q or 10-K to understand the urgency of this capital raise.